Tie Chong

1.5k total citations
78 papers, 1.0k citations indexed

About

Tie Chong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Tie Chong has authored 78 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 19 papers in Urology. Recurrent topics in Tie Chong's work include Epigenetics and DNA Methylation (14 papers), Renal cell carcinoma treatment (12 papers) and Urological Disorders and Treatments (12 papers). Tie Chong is often cited by papers focused on Epigenetics and DNA Methylation (14 papers), Renal cell carcinoma treatment (12 papers) and Urological Disorders and Treatments (12 papers). Tie Chong collaborates with scholars based in China, Singapore and United Kingdom. Tie Chong's co-authors include Ziming Wang, Xue Li, Yibing Guan, Fangshi Xu, Hecheng Li, Zhenlong Wang, Mei Gao, Ke Gao, Hongliang Li and Zhaolun Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Tie Chong

75 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tie Chong China 18 420 306 290 203 113 78 1.0k
Zhiwen Chen China 20 562 1.3× 142 0.5× 261 0.9× 236 1.2× 174 1.5× 70 1.0k
Xiaoling Du China 24 605 1.4× 461 1.5× 277 1.0× 339 1.7× 76 0.7× 53 1.3k
Cheng Fang China 22 872 2.1× 219 0.7× 607 2.1× 197 1.0× 86 0.8× 57 1.4k
Marie G. Selzer United States 18 516 1.2× 124 0.4× 266 0.9× 222 1.1× 154 1.4× 21 1.5k
Toshinori Ando Japan 16 428 1.0× 102 0.3× 121 0.4× 293 1.4× 156 1.4× 56 962
Vitale Miceli Italy 18 361 0.9× 105 0.3× 225 0.8× 107 0.5× 242 2.1× 57 924
Jinyang Wang China 17 584 1.4× 82 0.3× 317 1.1× 115 0.6× 117 1.0× 47 1.2k
Guo Chen China 22 779 1.9× 204 0.7× 412 1.4× 185 0.9× 280 2.5× 108 1.5k
Charles Hudd United Kingdom 8 262 0.6× 236 0.8× 98 0.3× 191 0.9× 106 0.9× 20 815
Takeo Fujii United States 17 301 0.7× 266 0.9× 327 1.1× 509 2.5× 99 0.9× 76 1.3k

Countries citing papers authored by Tie Chong

Since Specialization
Citations

This map shows the geographic impact of Tie Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tie Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tie Chong more than expected).

Fields of papers citing papers by Tie Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tie Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tie Chong. The network helps show where Tie Chong may publish in the future.

Co-authorship network of co-authors of Tie Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Tie Chong. A scholar is included among the top collaborators of Tie Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tie Chong. Tie Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abbas, Ansar, Xiaoqian Zhang, Sameer Hussain, et al.. (2025). Stimulus-responsive Pickering emulsion droplet-based microreactors for green biphasic catalysis. Communications Chemistry. 8(1). 322–322.
2.
3.
Liu, Xueyi, Pei Zhang, Sameer Hussain, et al.. (2025). Stimuli-Responsive Biomimetic Nanoplatform with in Situ Generated Camouflage for Synergistic Therapy of Prostate Cancer. ACS Applied Nano Materials. 8(9). 4530–4541. 1 indexed citations
4.
5.
6.
Guan, Yibing, Fangshi Xu, Juanhua Tian, et al.. (2022). Prognostic value of circulating tumor cells and immune-inflammatory cells in patients with renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 40(4). 167.e21–167.e32. 13 indexed citations
7.
8.
Qin, Xiaojian, Dongmei Ji, Weijie Gu, et al.. (2022). Activity and safety of SHR3680, a novel antiandrogen, in patients with metastatic castration-resistant prostate cancer: a phase I/II trial. BMC Medicine. 20(1). 84–84. 10 indexed citations
9.
An, Tian, et al.. (2022). Comprehensive analysis of the collagen family members as prognostic markers in clear cell renal cell carcinoma. Translational Cancer Research. 11(7). 1954–1969. 2 indexed citations
10.
Guan, Yibing, Fangshi Xu, Juanhua Tian, et al.. (2021). The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma. BMC Cancer. 21(1). 826–826. 29 indexed citations
11.
Zhang, Fang, Ke Chen, Wei Li, et al.. (2021). Expression patterns and prognostic value of RUNX genes in kidney cancer. Scientific Reports. 11(1). 14934–14934. 6 indexed citations
12.
Xu, Fangshi, Yibing Guan, Peng Zhang, et al.. (2020). The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma. Genes & Genomics. 42(9). 1055–1066. 10 indexed citations
13.
Wang, Zhenlong, et al.. (2019). Association of ATG7 Polymorphisms and Clear Cell Renal Cell Carcinoma Risk. Current Molecular Medicine. 19(1). 40–47. 7 indexed citations
14.
Li, Min, et al.. (2018). Effect of dual mTOR inhibitor on TGFβ1-induced fibrosis in primary human urethral scar fibroblasts. Biomedicine & Pharmacotherapy. 106. 1182–1187. 15 indexed citations
15.
16.
Song, Yun, Kunyi Wu, Weiju Wu, et al.. (2018). Epithelial C5aR1 Signaling Enhances Uropathogenic Escherichia coli Adhesion to Human Renal Tubular Epithelial Cells. Frontiers in Immunology. 9. 949–949. 7 indexed citations
17.
Wang, Zhenlong, Hecheng Li, & Tie Chong. (2017). A prospective, randomised trial comparing transurethral enucleation with bipolar system (TUEB) to monopolar resectoscope enucleation of the prostate for symptomatic benign prostatic hyperplasia. Biomedical Research-tokyo. 28(12). 5432–5437.
18.
Chen, Qi, et al.. (2017). Screening disrupted molecular functions and pathways associated with clear cell renal cell carcinoma using Gibbs sampling. Computational Biology and Chemistry. 70. 15–20. 1 indexed citations
19.
Zhang, Hongyi, Jie Cui, Ye Zhang, et al.. (2016). Isoflavones and Prostate Cancer. Chinese Medical Journal. 129(3). 341–347. 33 indexed citations
20.
Chong, Tie, Hecheng Li, Huibo Zhang, et al.. (2011). Rapamycin Inhibits Formation of Urethral Stricture in Rabbits. Journal of Pharmacology and Experimental Therapeutics. 338(1). 47–52. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiwen Chen Breakdown of academic impact, for papers by Xiaoling Du Breakdown of academic impact, for papers by Cheng Fang Breakdown of academic impact, for papers by Marie G. Selzer Breakdown of academic impact, for papers by Toshinori Ando Breakdown of academic impact, for papers by Vitale Miceli Breakdown of academic impact, for papers by Jinyang Wang Breakdown of academic impact, for papers by Guo Chen Breakdown of academic impact, for papers by Charles Hudd Breakdown of academic impact, for papers by Takeo Fujii
Rankless by CCL
2026